|
HY-135042-10mg
|
MedChemexpress LLC
|
CAY10614 [CAS 1202208-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-135042-100mg
|
MedChemexpress LLC
|
CAY10614 [CAS 1202208-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-135042-25mg
|
MedChemexpress LLC
|
CAY10614 [CAS 1202208-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-135042-5mg
|
MedChemexpress LLC
|
CAY10614 [CAS 1202208-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-135042-50mg
|
MedChemexpress LLC
|
CAY10614 [CAS 1202208-36-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P3912A-1mg
|
MedChemexpress LLC
|
Endotoxin inhibitor (TFA)
|
|
|
|
|
HY-P3912A-10mg
|
MedChemexpress LLC
|
Endotoxin inhibitor (TFA)
|
|
|
|
|
HY-P3912A-5mg
|
MedChemexpress LLC
|
Endotoxin inhibitor (TFA)
|
|
|
|
|
HY-N0223-1mg
|
MedChemexpress LLC
|
Epibetulinic acid [CAS 38736-77-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N0223-5mg
|
MedChemexpress LLC
|
Epibetulinic acid [CAS 38736-77-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-110133-10mg
|
MedChemexpress LLC
|
JTE-607 [CAS 188791-09-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-110133-100mg
|
MedChemexpress LLC
|
JTE-607 [CAS 188791-09-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-110133-25mg
|
MedChemexpress LLC
|
JTE-607 [CAS 188791-09-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-110133-5mg
|
MedChemexpress LLC
|
JTE-607 [CAS 188791-09-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-110133-50mg
|
MedChemexpress LLC
|
JTE-607 [CAS 188791-09-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-110133-1mL
|
MedChemexpress LLC
|
JTE-607 [CAS 188791-09-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N8277-1mg
|
MedChemexpress LLC
|
Kdo2-Lipid A (ammonium) [CAS 1246298-62-3]
|
|
|
|
|
HY-D1056-10mg
|
MedChemexpress LLC
|
Lipopolysaccharides
|
|
COVID-19-immunoregulation
|
|
|
HY-D1056-100mg
|
MedChemexpress LLC
|
Lipopolysaccharides
|
|
COVID-19-immunoregulation
|
|
|
HY-D1056-25mg
|
MedChemexpress LLC
|
Lipopolysaccharides
|
|
COVID-19-immunoregulation
|
|
|
HY-D1056-5mg
|
MedChemexpress LLC
|
Lipopolysaccharides
|
|
COVID-19-immunoregulation
|
|
|
HY-D1056-50mg
|
MedChemexpress LLC
|
Lipopolysaccharides
|
|
COVID-19-immunoregulation
|
|
|
HY-P3496-1mg
|
MedChemexpress LLC
|
Pep19-2.5 [CAS 1322711-38-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P3496-10mg
|
MedChemexpress LLC
|
Pep19-2.5 [CAS 1322711-38-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P3496-5mg
|
MedChemexpress LLC
|
Pep19-2.5 [CAS 1322711-38-5]
|
|
COVID-19-immunoregulation
|
|
